Cigna Group (NYSE:CI) Given New $306.00 Price Target at Robert W. Baird

Cigna Group (NYSE:CI) had its target price decreased by Robert W. Baird from $315.00 to $306.00 in a report issued on Wednesday,MarketScreener reports. Robert W. Baird currently has an outperform rating on the health services provider’s stock.

A number of other analysts have also issued reports on the stock. Sanford C. Bernstein upgraded shares of Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price objective for the company from $307.00 to $358.00 in a research note on Thursday, March 12th. Piper Sandler dropped their price objective on shares of Cigna Group from $374.00 to $370.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Jefferies Financial Group lifted their price objective on shares of Cigna Group from $310.00 to $333.00 and gave the company a “buy” rating in a research note on Monday, February 9th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Cigna Group from $301.00 to $304.00 and gave the company a “buy” rating in a research note on Tuesday, February 10th. Finally, Mizuho set a $325.00 price objective on shares of Cigna Group in a research note on Friday, January 9th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $332.63.

Cigna Group Trading Down 1.3%

NYSE CI opened at $269.01 on Wednesday. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company’s 50 day moving average price is $276.32 and its 200 day moving average price is $278.23. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.74 and a current ratio of 0.74. The firm has a market capitalization of $70.89 billion, a price-to-earnings ratio of 12.13, a PEG ratio of 0.94 and a beta of 0.26.

Cigna Group (NYSE:CI) last posted its quarterly earnings results on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. The firm had revenue of $72.50 billion for the quarter, compared to analyst estimates of $69.53 billion. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. Cigna Group’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the firm posted $6.64 earnings per share. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 19th. Shareholders of record on Thursday, March 5th were paid a dividend of $1.56 per share. The ex-dividend date was Thursday, March 5th. This is a positive change from Cigna Group’s previous quarterly dividend of $1.51. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s payout ratio is presently 28.13%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $666,515.37. Following the completion of the sale, the insider owned 32,647 shares in the company, valued at $9,432,044.77. The trade was a 6.60% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Everett Neville sold 1,719 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the sale, the insider owned 5,670 shares of the company’s stock, valued at approximately $1,638,119.70. The trade was a 23.26% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.60% of the stock is owned by insiders.

Hedge Funds Weigh In On Cigna Group

Several hedge funds and other institutional investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its holdings in shares of Cigna Group by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after acquiring an additional 414,834 shares during the period. State Street Corp boosted its holdings in shares of Cigna Group by 1.8% during the fourth quarter. State Street Corp now owns 12,339,250 shares of the health services provider’s stock valued at $3,396,132,000 after acquiring an additional 224,122 shares during the period. Massachusetts Financial Services Co. MA boosted its holdings in shares of Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after acquiring an additional 903,334 shares during the period. Dodge & Cox boosted its holdings in shares of Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock valued at $3,065,681,000 after acquiring an additional 1,833,389 shares during the period. Finally, Sanders Capital LLC boosted its holdings in shares of Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after acquiring an additional 35,150 shares during the period. Institutional investors and hedge funds own 86.99% of the company’s stock.

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.